After spending most of the year hunting for options to stay afloat, cash-strapped Portage Biotech appears to have found ...

Alex Pickett, CEO of Portage Biotech, commented: "We are excited about this opportunity to partner with Immunova. This ...

Shares of Portage Biotech Inc (PRTG) are up nearly 200% at $9.14 in premarket trading, following the announcement of a Letter of ...

Portage Biotech (PRTG) has entered into a Letter of Intent with Immunova, a private Connecticut-based biotechnology company. Under the terms of ...

Under the terms of the LOI, Portage and Immunova have agreed to negotiate a definitive option agreement for Immunova or an affiliate to acquire the entire share capital of iOx Therapeutics, ...

Portage Biotech stock is trading higher after the company announced it signed a letter of intent with Immunova for the ...

(RTTNews) - Shares of Portage Biotech Inc (PRTG) are up nearly 200% at $9.14 in premarket trading, following the announcement of a Letter of Intent with Immunova LLC, a Connecticut-based ...